SCHEMBL9760924

SCHEMBL9760924

CN(C)c1nc(CCCCN)c([N+](=O)[O-])s1

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
SSTR1 P30872 1/20 0.30
SSTR2 P30874 1/20 0.30
SSTR3 P32745 1/20 0.30
SSTR5 P35346 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9762360 0.79 ALDH1A1 (0.33) MAPTSSTR1SSTR2SSTR3SSTR5
SCHEMBL9762348 0.73
SCHEMBL9761412 0.73
SCHEMBL9762538 0.69 SMN1; SMN2 (0.38) MAPTRAB9A
SCHEMBL1101351 0.69 ALDH1A1 (0.39) MAPTRAB9A
SCHEMBL9761823 0.69
SCHEMBL9762396 0.69 MAPT (0.33) MAPT
SCHEMBL9761308 0.68 NPC1 (0.43) MAPTRAB9A
SCHEMBL10400605 0.67 HRH1 (0.33) SSTR1SSTR2SSTR3SSTR5
SCHEMBL11326258 0.67 ALDH1A1 (0.37) MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed